Primary Information |
|---|
| BoMiProt ID | Bomi5 |
|---|
| Protein Name | Complement C4 |
|---|
| Organism | Bos taurus |
|---|
| Uniprot ID | P01030 |
|---|
| Milk Fraction | Whey |
|---|
| Aminoacid Length | 920 |
|---|
| Molecular Weight | 101885 |
|---|
| FASTA Sequence |
Download |
|---|
| Gene Name | C4 |
|---|
| Protein Existence Status | Reviewed: Experimental evidence at protein level |
|---|
Secondary Information |
|---|
| Protein Function | most heterogeneous protein of the complement system; act as opsonizing molecules; C4b2a complex (the CP C3 convertase) remains on the activator and
mediates downstream activation by cleaving C3 into C3b and C3a; C4b may offer
a nucleophile for the cleavage of the thioester in nascent C3b |
|---|
| Biochemical Properties | C4A is more prone to attach to amine groups
of an activator, whereas C4B reacts preferentially with hydroxyl
groups; |
|---|
| Significance in milk | recruit inflammatory
leucocytes to the sites of an inflammation and activate their
effector mechanisms |
|---|
| PTMs | Glycosylated: 4 N linked glycosylation site; α and ß-chains are glycosylated, but no
accurate assessment of carbohydrate content in the
γ-chain has been reported; C4 in human plasma contains
mannose, galactose, glucosamine and sialic acid; contain
complex biantennary glycans with varying degrees
of sialylation; Human C4A recovered from cerebrospinal fluid was identified to
contain an O-linked core 1 glycan; sulfation of three tyrosine residues |
|---|
Site(s) of PTM(s)
N-glycosylation,
O-glycosylation,
Phosphorylation
| |
|---|
| Predicted Disorder Regions | NA |
|---|
| DisProt Annotation | |
|---|
| TM Helix Prediction | 1TMH; (73-95) |
|---|
| Additional Comments | Carbohydrate incorporation can be blocked by tunicamycin; underglycosylated pro-C4 protein is
more rapidly catabolized than the corresponding
fully glycosylated protein; underglycosylated
native C4, produced in the presence of
tunicamycin, had approximately the same specific
biological activity as glycosylated C4 |